“…These data suggest that TIP39 increases [Ca 2+ ]i via PTH2R, and regulates calcium homeostasis in low extracellular calcium conditions. Furthermore, pretreatment with inhibitors of the IP3 pathway, such as calmodulin, phospholipase C, and inositol 1,4,5-trisphosphate receptors, reduced the effects of TIP39 from 17.8% to 5.7%, 6.0%, and 7.1%, respectively (Figure 4e, lower graphs), but the inhibitor of nicotinic acid adenine dinucleotide phosphate that targets acidic endolysosomal Ca 2+ stores (Park et al, 2015) and sarcoplasmic/endoplasmic reticulum Ca 2+ ATPase did not effectively block the TIP39 response (12.2% and 13.6%, respectively) (Figure 4e, upper-right two graphs).…”